Book Value per Share: tnfpharma.com (TNFA)

TNF Pharmaceuticals is implementing bioinformatics and automation for protein analysis in drug development. The book value per share on GURU.Markets demonstrates fundamental management quality, where the 17.47 mark serves as a key metric. The company is developing methods to combat cellular senescence through medical funds, focusing on the clinical validation of molecules within B2B partnerships.

TNF Pharma (TNFA): Share Book Value from 07/25/2024 to 09/25/2025

TNF Pharmaceuticals Inc. - analytical breakdowns and key metrics (TNFA)

- price and consensus price forecast:
Stock Price TNF Pharma|TNFA - Forecast Levels Chart
- market capitalization data:
Market Capitalization TNF Pharmaceuticals, Inc.|TNFA - Enterprise Value
- book capitalization data:
Net Assets per Single Share TNF Pharmaceuticals|TNFA - Net Asset Value|Market Capitalization to Book Value Ratio tnfpharma.com|TNFA - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital TNF Pharmaceuticals|TNFA - Long-Term Debt to Capital|Short-Term Debt to Equity TNF Pharma|TNFA - Aggregate Debt Obligations|Debt to Book Capitalization Ratio TNF Pharmaceuticals, Inc.
Fundamental company valuation:tnfpharma.com - TNFA

To assess the financial stability of TNF Pharmaceuticals (TNFA), it is essential to track net asset capitalization, which supports the development of the biopharmaceutical ecosystem's patent perimeter. This metric is calculated as the ratio of equity to the number of shares outstanding; therefore, this book value per share chart clearly demonstrates the pace of asset accumulation and the efficiency of reinvesting profits into the development of targeted inhibitors.

Competitors of TNF Pharmaceuticals (TNFA)

Book Value per Share Haleon Group|KVUE - Share Book Value|VRNA: Book Value per Share|MENS (jyongbio.com) - Book Value per Share|Net Assets per Single Share Ligand LGND|Share Book Value Amneal Pharmaceuticals, Inc.|Perrigo Company (PRGO) - Book Value per Share|Accounting Value of a Share Alvotech Biopharmaceuticals (ALVO)|Book Value per Share LQDA (Liquidia Corporation)|glpg.com - Book Value per Share|Net Assets per Single Share ANI Pharmaceuticals, Inc. (ANIP)|MNKD: Accounting Value of a Share|AMPH (Amphastar) - Net Assets per Single Share|Pacira Corp (PCRX) - Accounting Value per Share|SPRY (ARS Pharmaceuticals) - Book Value per Share|Book Value per Share theravance.com (TBPH)|Aquestive Therapeutics, Inc. (AQST) - Accounting Value per Share|Accounting Value of a Share SCPH (scpharmaceuticals.com)|TECX: Net Assets per Single Share|TNXP - Net Asset Value per Share|Accounting Value per Share SXT China SXTC|EPRX - Book Price of a Share|Book Value per Share BioHarvest Sciences Inc. BHST|Invizyne Technologies (EXOZ) - Accounting Value of a Share|Book Value per Share ORMP (Oramed)|Net Asset Value per Share ENTX|MindWalk Holdings (HYFT) - Net Assets per Single Share|Accounting Value of a Share abvcpharma.com ABVC|Accounting Value per Share Cumberland Pharmaceuticals Inc. (CPIX)|Quantum BioPharma Ltd. - Book Price of a Share|FibroGen Corp (FGEN) - Net Assets per Single Share|TELO - Equity per Share|Book Value per Share ranitherapeutics.com (RANI)|Share Book Value Synergy CHC|RLYB - Accounting Value per Share|Accounting Value of a Share LEXX|PULM - Net Assets per Single Share|Share Book Value ftzy.com.cn (PTHL)|Book Value per Share Aptorum Group|Accounting Value of a Share lyratherapeutics.com LYRA|Impact BioMedical Inc - Book Value per Share|YCBD: Book Value per Share|Net Assets per Single Share PainReform Limited PRFX|CYTO (Altamira Therapeutics Ltd.) - Accounting Value of a Share|Net Assets per Single Share LIPO|Accounting Value per Share optinose.com|Book Value per Share PIRS|Book Value per Share Procaps Group (PROC)|Petros - Book Value per Share|Accounting Value per Share Qilian International Corp QLI|SLRN (Acelyrin, Inc.) - Book Value per Share|tffpharma.com (TFFP) - Net Asset Value per Share